Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $380.57 million. The enterprise value is $282.66 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 22.79 million shares outstanding. The number of shares has increased by 78.82% in one year.
| Current Share Class | 22.79M |
| Shares Outstanding | 22.79M |
| Shares Change (YoY) | +78.82% |
| Shares Change (QoQ) | +30.22% |
| Owned by Insiders (%) | 3.14% |
| Owned by Institutions (%) | 81.84% |
| Float | 17.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6,450.29 |
| Forward PS | n/a |
| PB Ratio | 3.72 |
| P/TBV Ratio | 5.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4,790.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.14, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.14 |
| Quick Ratio | 7.60 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -72.43% and return on invested capital (ROIC) is -41.93%.
| Return on Equity (ROE) | -72.43% |
| Return on Assets (ROA) | -34.12% |
| Return on Invested Capital (ROIC) | -41.93% |
| Return on Capital Employed (ROCE) | -70.45% |
| Weighted Average Cost of Capital (WACC) | 9.43% |
| Revenue Per Employee | $1,788 |
| Profits Per Employee | -$2.37M |
| Employee Count | 33 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $165,000 in taxes.
| Income Tax | 165,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.49% in the last 52 weeks. The beta is 0.94, so AVTX's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +108.49% |
| 50-Day Moving Average | 15.50 |
| 200-Day Moving Average | 13.24 |
| Relative Strength Index (RSI) | 60.25 |
| Average Volume (20 Days) | 839,311 |
Short Selling Information
The latest short interest is 4.09 million, so 17.94% of the outstanding shares have been sold short.
| Short Interest | 4.09M |
| Short Previous Month | 3.68M |
| Short % of Shares Out | 17.94% |
| Short % of Float | 23.70% |
| Short Ratio (days to cover) | 6.61 |
Income Statement
In the last 12 months, AVTX had revenue of $59,000 and -$78.26 million in losses. Loss per share was -$5.84.
| Revenue | 59,000 |
| Gross Profit | -35.29M |
| Operating Income | -72.93M |
| Pretax Income | -78.09M |
| Net Income | -78.26M |
| EBITDA | -72.58M |
| EBIT | -72.93M |
| Loss Per Share | -$5.84 |
Full Income StatementBalance Sheet
The company has $98.34 million in cash and $427,000 in debt, with a net cash position of $97.91 million or $4.30 per share.
| Cash & Cash Equivalents | 98.34M |
| Total Debt | 427,000 |
| Net Cash | 97.91M |
| Net Cash Per Share | $4.30 |
| Equity (Book Value) | 83.05M |
| Book Value Per Share | 4.49 |
| Working Capital | 92.35M |
Full Balance SheetCash Flow
| Operating Cash Flow | -51.46M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 344,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -51.46M |
| FCF Per Share | -$2.26 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -123,601.69% |
| Pretax Margin | -132,362.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.82% |
| Shareholder Yield | -78.82% |
| Earnings Yield | -20.56% |
| FCF Yield | -13.52% |
Analyst Forecast
The average price target for AVTX is $36.80, which is 120.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.80 |
| Price Target Difference | 120.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 336.20% |
| EPS Growth Forecast (5Y) | -22.92% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
AVTX has an Altman Z-Score of -4.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.18 |
| Piotroski F-Score | 1 |
